Pentwater Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,000
| Closed | -$393K | – | 300 |
|
|
2021
Q1 | $393K | Sell |
3,000
-500
| -14% | -$65.5K | ﹤0.01% | 242 |
|
|
2020
Q4 | $366K | Sell |
3,500
-15,000
| -81% | -$1.57M | ﹤0.01% | 169 |
|
|
2020
Q3 | $1.31M | Sell |
18,500
-10,000
| -35% | -$708K | 0.02% | 109 |
|
|
2020
Q2 | $1.83M | Buy |
28,500
+10,000
| +54% | +$642K | 0.03% | 55 |
|
|
2020
Q1 | $554K | Sell |
18,500
-16,500
| -47% | -$494K | 0.01% | 73 |
|
|
2019
Q4 | $685K | Buy |
35,000
+18,000
| +106% | +$352K | 0.01% | 75 |
|
|
2019
Q3 | $271K | Buy |
+17,000
| New | +$271K | ﹤0.01% | 101 |
|
|
2019
Q2 | – | Sell |
-10,000
| Closed | -$204K | – | 148 |
|
|
2019
Q1 | $204K | Sell |
10,000
-10,000
| -50% | -$204K | ﹤0.01% | 102 |
|
|
2018
Q4 | $305K | Buy |
+20,000
| New | +$305K | ﹤0.01% | 95 |
|